Otsuka Holdings Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Otsuka Holdings Company Limited with three other
companies in this sector in Japan:
Astellas Pharma Incorporated
sales of 1.37 trillion Japanese Yen [US$12.33 billion]
of which 57%
Daiichi Sankyo Company Limited
(986.45 billion Japanese Yen [US$8.86 billion]
of which 94%
was prescription drugs), and
Takeda Pharmaceutical Company Limited
(1.81 trillion Japanese Yen [US$16.23 billion]
of which 91%
was Pharmaceutical Business).
During the year ended December of 2016, sales at
Otsuka Holdings Company Limited were ¥1.20 trillion (US$10.74 billion).
decrease of 17.3%
versus 2015, when the company's sales were ¥1.45 trillion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Otsuka Holdings Company Limited had sales
of ¥1.09 trillion.